Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Results are expressed as pmol/mg protein
According to KFF analysis of Centers for Medicare & Medicaid Services 2018-2022 Medicare Part D spending by drug increased from $57 Million to $5.7 Billion.[2] The June 13, 2024 article in Fierce Healthcare[3] on GLP-1 drugs noted that Blue Cross Blue Shield of Michigan will no longer cover these drugs starting in January 2025, and will be changing the prior authorization criteria starting in August 2024, for those members that are in large group fully insured commercial plans
Cons and Considerations GLP-1 medications can be effective, but they are not a quick fix
some categories, notably protein-rich and/or gut-friendly products are doing quite well with increases of 5 to 10% depending on the sources
As there is an emphasis on preventive medicine in the healthcare industry and the treatment of metabolic diseases, demand for these oral medications will keep on increasing in the forecast period
US$ 22.39
US$ 29.08
US$ 27.97
US$ 20.61
